FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130398517> ?p ?o ?g. }

• W2130398517 endingPage "1399" @default.
• W2130398517 startingPage "1393" @default.
• W2130398517 abstract "ABSTRACT New Zealand (NZ) has experienced a Neisseria meningitidis serogroup B epidemic since 1991. MeNZB, a strain-specific outer membrane vesicle vaccine made using an NZ epidemic strain isolate, NZ98/254 (B:4:P1.7b,4), from two manufacturing sites, the Norwegian Institute of Public Health (NIPH) and Chiron Vaccines (CV; now Novartis), was evaluated for safety, immunogenicity, and reactogenicity in this observer-blind trial with 8- to 12-year-old children. In year 1, cohort A ( n = 302) was randomized 4:1 for receipt of NIPH-MeNZB or MenBvac (Norwegian parent vaccine strain 44/76; B:15:P1.7,16). In year 2, cohort B ( n = 313) was randomized 4:1 for receipt of CV-MeNZB or NIPH-MeNZB. Participants all received three vaccinations 6 weeks apart. Local and systemic reactions were monitored for 7 days. Seroresponse was defined as a fourfold or greater rise in the serum bactericidal antibody titer from the baseline titer as measured by a serum bactericidal assay. Those with baseline titers of <1:4 required titers of ≥1:8 to serorespond. Intention-to-treat (ITT) and per protocol (PP) analyses are presented. In cohort A, 74% (ITT) and 73% (PP) of NIPH-MeNZB recipients demonstrated seroresponses against NZ98/254 after three doses, versus 32% (ITT and PP) of MenBvac recipients. In cohort B, seroresponses against NZ98/254 after three doses occurred in 79% (ITT and PP) of CV-MeNZB versus 75% (ITT) and 76% (PP) of NIPH-MeNZB recipients. Vaccines were tolerable, with no vaccine-related serious adverse events. In conclusion, the NZ strain meningococcal B vaccine (MeNZB) from either manufacturing site was immunogenic against New Zealand epidemic vaccine strain meningococci with no safety concerns when given in three doses to these 8- to 12-year-old children." @default.
• W2130398517 created "2016-06-24" @default.
• W2130398517 creator A5002546126 @default.
• W2130398517 creator A5009295901 @default.
• W2130398517 creator A5014274576 @default.
• W2130398517 creator A5016248743 @default.
• W2130398517 creator A5019754173 @default.
• W2130398517 creator A5020266399 @default.
• W2130398517 creator A5021632560 @default.
• W2130398517 creator A5022157563 @default.
• W2130398517 creator A5023063553 @default.
• W2130398517 creator A5030243840 @default.
• W2130398517 creator A5034073333 @default.
• W2130398517 creator A5038657366 @default.
• W2130398517 creator A5066494288 @default.
• W2130398517 date "2007-11-01" @default.
• W2130398517 modified "2023-09-27" @default.
• W2130398517 title "Immunogenicity, Reactogenicity, and Safety of a P1.7b,4 Strain-Specific Serogroup B Meningococcal Vaccine Given to Preteens" @default.
• W2130398517 cites W1510773753 @default.
• W2130398517 cites W1904850674 @default.
• W2130398517 cites W19323755 @default.
• W2130398517 cites W1991844560 @default.
• W2130398517 cites W1993364027 @default.
• W2130398517 cites W1998558781 @default.
• W2130398517 cites W2007385447 @default.
• W2130398517 cites W2016211970 @default.
• W2130398517 cites W2019800418 @default.
• W2130398517 cites W2033366028 @default.
• W2130398517 cites W2037308991 @default.
• W2130398517 cites W2039230753 @default.
• W2130398517 cites W2044099387 @default.
• W2130398517 cites W2046267384 @default.
• W2130398517 cites W2048133146 @default.
• W2130398517 cites W2052605202 @default.
• W2130398517 cites W2057128472 @default.
• W2130398517 cites W2098499618 @default.
• W2130398517 cites W2115350923 @default.
• W2130398517 cites W2122026995 @default.
• W2130398517 cites W2130776699 @default.
• W2130398517 cites W2132306802 @default.
• W2130398517 cites W2144354156 @default.
• W2130398517 cites W2151921752 @default.
• W2130398517 cites W2159472720 @default.
• W2130398517 cites W2412744566 @default.
• W2130398517 cites W43534825 @default.
• W2130398517 doi "https://doi.org/10.1128/cvi.00167-07" @default.
• W2130398517 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2168176" @default.
• W2130398517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17898183" @default.
• W2130398517 hasPublicationYear "2007" @default.
• W2130398517 type Work @default.
• W2130398517 sameAs 2130398517 @default.
• W2130398517 citedByCount "26" @default.
• W2130398517 countsByYear W21303985172015 @default.
• W2130398517 countsByYear W21303985172016 @default.
• W2130398517 countsByYear W21303985172017 @default.
• W2130398517 countsByYear W21303985172018 @default.
• W2130398517 countsByYear W21303985172019 @default.
• W2130398517 countsByYear W21303985172020 @default.
• W2130398517 countsByYear W21303985172021 @default.
• W2130398517 crossrefType "journal-article" @default.
• W2130398517 hasAuthorship W2130398517A5002546126 @default.
• W2130398517 hasAuthorship W2130398517A5009295901 @default.
• W2130398517 hasAuthorship W2130398517A5014274576 @default.
• W2130398517 hasAuthorship W2130398517A5016248743 @default.
• W2130398517 hasAuthorship W2130398517A5019754173 @default.
• W2130398517 hasAuthorship W2130398517A5020266399 @default.
• W2130398517 hasAuthorship W2130398517A5021632560 @default.
• W2130398517 hasAuthorship W2130398517A5022157563 @default.
• W2130398517 hasAuthorship W2130398517A5023063553 @default.
• W2130398517 hasAuthorship W2130398517A5030243840 @default.
• W2130398517 hasAuthorship W2130398517A5034073333 @default.
• W2130398517 hasAuthorship W2130398517A5038657366 @default.
• W2130398517 hasAuthorship W2130398517A5066494288 @default.
• W2130398517 hasBestOaLocation W21303985171 @default.
• W2130398517 hasConcept C126322002 @default.
• W2130398517 hasConcept C147483822 @default.
• W2130398517 hasConcept C159047783 @default.
• W2130398517 hasConcept C159654299 @default.
• W2130398517 hasConcept C197934379 @default.
• W2130398517 hasConcept C203014093 @default.
• W2130398517 hasConcept C22070199 @default.
• W2130398517 hasConcept C2777704310 @default.
• W2130398517 hasConcept C2778458888 @default.
• W2130398517 hasConcept C2780868878 @default.
• W2130398517 hasConcept C32611913 @default.
• W2130398517 hasConcept C523546767 @default.
• W2130398517 hasConcept C54355233 @default.
• W2130398517 hasConcept C71924100 @default.
• W2130398517 hasConcept C72563966 @default.
• W2130398517 hasConcept C86803240 @default.
• W2130398517 hasConceptScore W2130398517C126322002 @default.
• W2130398517 hasConceptScore W2130398517C147483822 @default.
• W2130398517 hasConceptScore W2130398517C159047783 @default.
• W2130398517 hasConceptScore W2130398517C159654299 @default.
• W2130398517 hasConceptScore W2130398517C197934379 @default.
• W2130398517 hasConceptScore W2130398517C203014093 @default.
• W2130398517 hasConceptScore W2130398517C22070199 @default.
• W2130398517 hasConceptScore W2130398517C2777704310 @default.

• next